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ABSTRACT 
Several approaches are currently used to retain the dosage form in the stomach. These include bioadhesive systems, swelling and expanding 
systems, floating systems   and other delayed gastric emptying devices. The principle of floating tablets offers a simple and practical approach to 
achieve increased gastric residence time to enhance the bioavailability and to obtain controlled release. Floating tablets are designed based on 
gas generating principle. Design of floating tablets needs a strong matrix forming polymer. Though several polymers are available for floating 
tablets, there is a continued need to develop new, effective and efficient polymers for controlled release floating tablets. The major objective of 
the investigation is to evaluate starch-urea-borate, a new modified starch as a floating matrix former in the design of controlled release floating 
tablets. 
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INTRODUCTION 
Several approaches are currently used to retain the dosage 
form in the stomach. The principle of floating tablets is 
simple and practical approach to achieve increased gastric 
residence time to enhance the oral bioavailability and to 
obtain controlled release. Floating tablets designed based on 
gas generating principle needs a strong floating matrix 
former. Starch –urea-borate, a new modified starch was tried 
as floating matrix former in the design of floating tablets. 
The present investigation deals with an attempt of 
systematic formulation approach for optimization of floating 
tablets of carbamazepine (a poorly soluble BCS-Class II drug) 
employing starch-urea-borate as new floating matrix former, 
sodium bicarbonate as gas generating agent, bees wax and 
ethyl cellulose as floating enhancers. A 23 - Factorial design 
was applied to investigate the main and interaction effects of 
the three formulation variables i.e, sodium bicarbonate (A), 
ethyl cellulose (B) and bees wax (C) in each case to develop a 
floating formulation with more floating time and to permit 
rational selection of a batch of floating tablets with 
controlled dissolution profile over a period of 24 h.   
MATERIALS 
Carbamazepine was a gift from M/s. Ranbaxy Research Labs., 
Gurgaon, Haryana.  
Starch-urea-borate prepared in Potato starch (Loba Chemie) 
Urea (Qualigens) 
Borax (Qualigens) 
Ethyl cellulose (viscosity of 5% w/w solution in 80 : 20 
toluene : ethanol by weight at 250C in 18 cps, containing not 
less than 46.5% ethoxyl groups). (Loba-chemie).  
Bees wax. I. P (Moksha life style products, New Delhi) 
Sodium bicarbonate (SD Fine Chemie) 
Magnesium stearate (Loba Chemie) 
Talc I.P  (Loba Chemie) 
All other ingredients used were of analytical grade and used 
as received. 
METHODS 
Preparation of starch – urea – borate:  
Starch–urea–borate was synthesized by gelatinizing potato 
starch in the presence of borax and urea. 
Potato starch (50 g) was dispersed in 100 ml of purified 
water to form starch slurry. Borax (10.0 g) and urea (15.0 g) 
were dissolved separately in   400 ml of purified water and 
the solution was heated to boiling. While boiling, the starch 
slurry was added and mixed. Mixing while heating was 
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continued for 10 minutes to gelatinize starch to form starch–
urea–borate polymer. The mass formed was spread on to a 
stainless steel plate and dried at 800C for 6 – 8 h. The dried 
polymer was powdered and passed through mesh no. 120.  
Characterization of starch – urea – borate: 
The starch – urea – borate prepared was characterized by 
microscopical examination, chemical and physical tests to 
determine its melting point, solubility, swelling index, pH, 
viscosity and various micromeritic properties namely bulk 
density, tap density, compressibility index and angle of 
repose and also by DSC and FTIR spectra. 
1. Microscopic examination: 
Slurry (1 %) of each of potato starch and starch – urea – 
borate in a mixture of equal volumes of glycerin and water 
were prepared. A smear of the slurry was made and 
examined under microscope. Photomicrographs of potato 
starch and starch – urea – borate are shown in Figs. 1A, 1B, 
2A and 2B. The size of 100 particles was measured using a 
calibrated eye – piece micrometer. The particle size 
distribution of potato starch and starch – urea – borate 
(prepared) are given in Table 1.  
2. Chemical test: 
Iodine test:  
Slurry of starch – urea – borate in water was treated with 
iodine test solution. A reddish violet colour was observed 
indicating the presence of  - amylose. 
3. Melting point: 
Melting point of starch – urea – borate was determined in a 
melting point apparatus and also by DSC. 
4. Solubility:  
Solubility was tested in water, aqueous buffers of pH 1.2 and 
7.4, methanol, petroleum ether, dichloromethane, 
cyclohexane and chloroform. 
5. Swelling index: 
Starch – urea – borate (1 gm) was taken into two graduated 
50 ml measuring cylinders, one containing petroleum ether 
and other containing water and stored for 24 h. Swelling 
index of starch – urea – borate was determined using the 
formula 
Swelling index (%) = Vw – Vo    x   100 
             Vo 
Where, Vo is the volume of the sediment in petroleum ether 
and  
Vw is the volume of sediment in water after 24 h 
6. pH:  
The pH of a 0.1 % w/v aqueous dispersion was measured. 
7. Viscosity:  
Viscosity of a 0.1 % w/v homogenized dispersion was 
determined using Ostwald Viscometer.  
8. Density (g/cc): 
Density was determined by liquid displacement method 
using petroleum ether as liquid. 
9. Bulk and tap densities: 
Bulk and tap densities were determined by 3 tap method in a 
graduated cylinder. 
 
10. Compressibility index: 
Compressibility index was determined by measuring the 
initial volume (Vo) and final volume (V) after 100 tappings of 
a sample of starch – urea – borate in a measuring cylinder. 
Compressibility index was calculated using the equation, 
Compressibility index = Vo – V x 100 
      Vo 
11. Angle of repose:  
Angle of repose was determined by fixed funnel method. 
The physical and micromeritic properties of starch – urea – 
borate prepared are summarized in Table 2. 
Experimental Design: 
Optimization of the Carbamazepine floating tablets was done 
using 23 factorial design in which 3 factors, each at two levels 
were evaluated. To evaluate the individual and combined 
effects of sodium bicarbonate ( factor A), ethyl cellulose 
(factor B) and bees wax (factor C) on the in vitro buoyancy 
and drug release characteristics, the floating tablets were 
formulated using selected combinations of three factors as 
per 23 - factorial design. Formulae of carbamazepine floating 
tablets prepared as per 23 – factorial design are given in 
Table 3. 
Drug – Excipient Compatibility Studies 
The compatibility of starch-urea-borate with the selected 
drugs was evaluated by TLC studies. 
TLC Study: 
TLC was carried out on carbamazepine and its mixtures (1: 
1) with starch-urea-borate as follows: 
Stationary phase: Silica gel G (pre coated TLC plates). 
Mobile phase:  
Carbamazepine: Strong Ammonia Solution: Methanol (1.5: 
100) 
Diltiazem: Ethyl acetate: Methanol: Strong ammonia solution 
(80 : 10 : 10 v/v) 
Procedure:  
Mobile phase was prepared and taken in a TLC chamber. The 
chamber was allowed to saturate with solvent vapour for 24 
h. Standard (pure drug) and test (drug – starch-urea-borate 
mixtures) sample were spotted on activated silica plates 
using narrow capillary tubes. The spotted plates were kept in 
the TLC chamber and allowed to run the mobile phase. The 
plates were dried and kept in iodine chamber to develop the 
spots. The Rf values of standard and test samples were 
determined by the following formula. 
Rf = Distance travelled by sample / distance travelled by 
solvent front. 
The Rf values are given in Table 3. 
Preparation of Carbamazepine Floating Tablets: 
The tablets were prepared by melt granulation method. Bees 
wax was melted in a large porcelain dish and previously 
prepared geometric mixture of carbamazepine, starch-urea-
borate, ethyl cellulose and sodium bicarbonate was added to 
the molten bees wax and mixed thoroughly until it attained 
room temperature. The coherent mass was passed through 
mesh No 16 and the granules obtained were air dried. The 
lubricants talc (2%) and magnesium stearate (2%) were 
passed through mesh No.60 onto the dry granules and 
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blended in a closed polyethylene bag. The tablet granules 
were compressed into tablets on a 16 – station tablet 
punching machine (M/s Cadmach Machineries Pvt Ltd., 
Ahemedabad) to a hardness of 5-6 kg/sq.cm.  
Evaluation of Carbamazepine Floating Tablets: 
Estimation of Carbamazepine in tablets: 
Five tablets were accurately weighed and powdered. Tablet 
powder equivalent to 25 mg of medicament was taken into a 
150 ml conical flask and extracted with 3 X 25 ml methanol 
and the methonolic extracts were filtered and collected into 
a 100 ml volumetric flask. The solution was then made upto 
volume with methanol. The methanolic solution was 
subsequently diluted suitably with 0.1 N hydrochloric acid 
and assayed for carbamazepine at 288 nm. Four samples of 
tablet powder were analyzed in each case.   
Hardness: 
Hardness of the tablets was tested using a Monsanto 
Hardness Tester.  
Friability: 
Friability of the tablets was determined in a Roche 
Friabilator.  
In Vitro Buoyancy Studies: 
In Vitro buoyancy was determined by floating time as per the 
method described by Dave B.S et al1. The tablets were placed 
in a 250 ml glass beaker containing simulated gastric fluid 
(SGF), pH 1.2 as per USP. The time required for the tablet to 
rise to the surface and float was determined as floating lag 
time. The time period during which the tablet remains 
floating was determined as floating time. 
Dissolution Rate Study: 
The in vitro dissolution rate study of carbamazepine floating 
tablet was performed using 8-station dissolution test 
apparatus (Labindia Disso 2000) fitted with paddles (50 
rpm) at 37 ± 0.50 C, using simulated gastric fluid (pH 1.2; 900 
ml) as a dissolution media. At the predetermined time 
intervals, 5 ml samples were withdrawn, filtered through 
0.45 µ membrane filter, diluted, and assayed at 288 nm using 
a Elico UV/Visible Double beam spectrophotometer. 
Cumulative percentage drug release was calculated. 
Kinetic modeling of drug release: 
The dissolution profiles of all the batches was fitted to 
various models like zero-order, first order2, Korsmeyer and 
Peppas3-5, and Higuchi6 models to ascertain the kinetic 
modeling of drug release. 
Optimization: 
The percentages of sodium bicarbonate (A), ethyl cellulose 
(B) and bees wax (C) were selected as independent variables. 
The floating time and percent released at the end of 24 h 
were selected as dependent variables. 
  
 
RESULTS AND DISCUSSION 
Table 1: Particle Size Distribution of Potato Starch and Starch – urea – borate Prepared 
Size Range  
(m) 
Number of Particles 
Potato Starch Starch – urea – borate 
0 – 50 
50 – 100 
100 – 150 
150 – 200 
27 
60 
13 
-- 
-- 
20 
53 
27 
x  ± s.d (m) 67.5 ± 29.54 128.0 ± 33.21 
 
Table 2: Physical and Micromeritic Properties of Starch – urea – borate Prepared 
S. N. Property Result 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
Iodine test  
Melting Point 
Solubility 
Swelling index 
pH of 0.1 % aqueous dispersion 
Viscosity of a 0.1 % aqueous dispersion 
Density 
Tap density 
Compressibility index 
Angle of repose 
Positive indicates the presence of  - amylose  
Charred at 2100C 
Insoluble in water, aqueous fluids of acidic and alkaline pHs and in organic solvents 
Swells in water with a swelling index of 614.28 % 
9.01 
1.011 cps 
0.511 g/cc 
0.721 g/cc 
12.91 % 
220 761 
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Figure 1A: Photomicrographs of Potato Starch 
(unstained) 
 
 
Figure 1B: Photomicrographs of Potato Starch (stained 
with Saffranin) 
 
 
Figure 2A: Photomicrographs of Starch-urea-borate 
(unstained) 
 
 
Figure 2b: Photomicrographs of Starch-urea-borate 
(stained) 
 
Starch – urea – borate was prepared by gelatinizing potato 
starch in the presence of borax and urea. It is known1, 2 that 
starch reacts with urea to form starch carbamate, a starch – 
urea cross linked polymer. Khalil et al. investigated the 
reactions between starch and urea resulting in the formation 
of starch cross linked with urea. The reactions involved are 
as follows 
                                              heat 
St OH + CO(NH2)2                                     St OCONH2 + NH3 
 
                                           heat 
2 St OCONH2                                                               St OCONHCOOSt + NH3 
 
                                             heat 
St OH + StOCONH2                                St OCOOSt + NH3 
 
Where St OH is starch 
 
Sodium borate serves as a catalyst in the cross linking 
reaction between starch and urea. Literature on 
pharmaceutical applications of starch-urea-borate polymer 
is scanty. In one study4 it has been used in the controlled 
release formulation of insecticide acetamiprid. In another 
patent5a controlled release pesticide formulation was 
developed encapsulating the pesticide (deltamethrin) in a 
polymer matrix of starch-borax-urea. Chowdary K.P.R and 
Murali Krishna M.N used starch-urea-borate in the 
controlled release of gliclazde and diclofenac. In the present 
investigation starch-urea-borate was evaluated for its 
application as buoyant release retardant and rate controlling 
polymer in the design of floating controlled release 
formulations of selected drugs. The starch-urea-borate 
prepared was found to be fine, hard and free flowing 
crystalline powder.  The density of Starch-urea-borate was 
found to be 0.511 g/cc (less than the density of water), so it 
can be used in the formulation of floating drug delivery 
systems. The compressibility index of Starch-urea-borate 
was found to be 12.91% and the angle of repose was found 
to be 220761. Both compressibility index and angle of repose 
of Starch-urea-borate indicates that the polymer has 
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excellent flow properties, so the polymer can be used in the 
formulation of tablets. It gave a positive iodine test indicating 
the presence of - amylose.  
Microscopic examination indicated that potato starch 
consists oval shaped grains (Fig. 1A and 1B). Whereas 
starch-urea-borate consists of rectangular, transparent 
crystals (Fig. 2A and 2B). The particle size in each case was 
determined by microscopy. The results are given in Table 1. 
The average size of the potato starch grains was 66.5 ± 30.87 
m. The average size of starch-urea-borate crystals was 
127.0 ± 34.58 m.  
The physical and micromeritic properties of starch-urea-
borate prepared are summarized in Table 2. It was insoluble 
in water, aqueous fluids of acidic and alkaline pHs. It was 
also insoluble in organic solvents like methanol, petroleum 
ether, dichloromethane, cyclohexane and chloroform. The pH 
of a 0.1 % aqueous dispersion was 9.01. 
Starch-urea-borate exhibited good swelling in water. The 
swelling index was 614.28 %. The swelling of starch-urea-
borate matrix tablets in water is shown in Fig. 5. All 
micromeritic properties indicated good flow and 
compressibility needed for solid dosage form manufacturing. 
 
Table 3: Rf Values of Selected Drugs and their Mixtures 
(1: 1) with 
Starch-urea-borate 
S. No. Product Rf  Value 
1.  Carbamazepine 0.740 
2. Carbamazepine – Starch-urea-borate 0.735 
 
As starch-urea-borate has density of 0.511 g/cc (less than 
the density of water), excellent flow properties, good 
swelling property in water, it is considered as suitable 
buoyant release retarding and rate controlling polymer in 
floating tablets for obtaining the formulations that remain in 
the gastric region for prolonged period with controlled 
release of drug. 
 
(1) 
Figure 3: 1 (A) Carbamazepine pure drug (B) 
Carbamazepine and starch-urea-borate 
 In the TLC study, single spots were observed in the case of 
pure drugs as well as their mixtures with starch-urea-borate. 
The close agreement of the Rf values of the drugs and their 
mixtures with starch-urea-borate (Table 3) indicated no 
interaction between the drugs and starch-urea-borate.  
Thus the results of TLC indicated no interaction between the 
selected drugs and starch-urea-borate, the new starch based 
polymer developed. Hence, starch-urea-borate could be used 
as a floating matrix former in the design of floating drug 
delivery systems of the selected drugs.  
 
 
Table 4: Tablet Formulations as per 23 – Factorial Design 
Ingredient 
(mg/tablet) 
CFF1 CFF2 CFF3 CFF4 CFF5 CFF6 CFF7 CFF8 
Carbamazepine 50 50 50 50 50 50 50 50 
Bees wax 33 33 33 33 44 44 44 44 
SUB Polymer 85 63 74 52 74 52 63 41 
Sodium bicarbonate 22 44 22 44 22 44 22 44 
Ethyl Cellulose 22 22 33 33 22 22 33 33 
Talc 4 4 4 4 4 4 4 4 
Magnesium stearate 4 4 4 4 4 4 4 4 
Total Weight (mg) 220 220 220 220 220 220 220 220 
 
Table 5: Physical Properties: Hardness, Friability, Drug content, Floating lag time and Floating time of Carbamazepine 
Floating Tablets. 
Formulation Hardness (Kg/Cm2) ± S.D Friability 
(%) ± S.D 
Drug Content 
(mg/tab) ± S.D 
Floating Lag 
Time (m) ± S.D 
Floating 
Time (h) ± S.D 
CFF1 5.5 ± 0.05 0.12 ± 0.012 48.65 ± 0.42 5.1 ± 1.11 07.50 ± 0.051 
CFF2 6.0 ± 0.04 0.16 ± 0.013 49.82 ± 0.24  1.9 ± 0.61 03.00 ± 0.021 
CFF3 5.5 ± 0.08 0.18 ± 0.018 49.61 ± 0.36 1.2 ± 0.35 42.00 ± 0.032 
CFF4 5.0 ± 0.09 0.16 ± 0.015 47.32 ± 0.24 0.8 ± 0.21 03.66 ± 0.041 
CFF5 5.5 ± 0.45 0.18 ± 0.017 49.92 ± 0.02 0.6 ± 0.09 43.00 ± 0.056 
CFF6 5.5 ± 0.31 0.14 ± 0.016 48.82 ± 0.47 1.0 ± 0.29 04.33 ± 0.024 
CFF7 5.5 ± 0.57 0.16 ± 0.014 47.72 ± 0.34 2.1 ± 0.85 43.00 ± 0.031 
CFF8 5.5 ± 0.65 0.13 ± 0.010 48.37 ± 0.65 1.1 ± 0.22 33.85 ± 0.024 
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CFF1 Carbamazepine Floating Tablets 
At zero time             At T = 5.1 m              At T = 7.5 h 
 
CFF2 Carbamazepine Floating Tablets 
At zero time                  At T = 1.9 m                At T = 3.0 h 
 
CFF3 Carbamazepine Floating Tablets 
At zero time                At T = 1.2 m            At T = 42.0 h 
 
CFF4 Carbamazepine Floating Tablets 
At zero time            At T = 0.8 m               At T = 3.66 h 
 
Figure 4: CARBAMAZEPINE FLOATING TABLETS 
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CFF5 Carbamazepine Floating Tablets 
At zero time             At T = 0.6 m               At T = 43.0 h 
 
 
C FF6 Carbamazepine Floating Tablets 
At zero time           At T = 1.0 m             At T = 4.33 h 
 
 
CFF7 Carbamazepine Floating Tablets 
At zero time            At T = 2.1 m              At T = 43.0 h 
 
 
CFF8 Carbamazepine Floating Tablets 
At zero time               At T = 1.1 m              At T = 33 h 
 
Figure 4(a): CARBAMAZEPINE FLOATING TABLETS 
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Figure 5: Release Profiles of Carbamazepine  
Floating Tablets (CFF1-CFF4) 
 
Figure 6: Time Vs Log Percent Drug Remaining Plots for 
Carbamazepine Floating Tablets (CFF1-CFF4) 
 
 
Figure 7: Square Root Time Vs Percent Released Plots of 
Carbamazepine Floating Tablets (CFF1-CFF4) 
 
Figure 8: Log time Vs Log Percent Released Plots of 
Carbamazepine Floating Tablets (CFF1-CFF4) 
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Figure 9: Release Profiles of Carbamazepine Floating Tablets  
(CFF5-CFF8) 
 
Figure 10: Time Vs Log Percent Drug Remaining Plots 
for Carbamazepine Floating Tablets (CFF5-CFF8) 
 
 
Figure 11: Square Root Time Vs Percent Released Plots of 
Carbamazepine Floating Tablets (CFF5-CFF8) 
Figure 12: Log time Vs Log Percent Released Plots of 
Carbamazepine Floating Tablets (CFF5-CFF8) 
 
Table 6: Correlation Coefficient (R2) Values in the Analysis of Release Data as per Zero order, First order, Higuchi, and 
Peppas Equation Models. 
 
 
 
 
 
 
 
Table 7: Release Characteristics of Carbamazepine Floating Tablets 
Formulation % Release in 24 h 
± S.D 
K0 (mg/hr) K1 (/h) ‘n’ in peppas 
equation 
CFF1 74.47 ± 1.62 2.0229 0.07439 0.634 
CFF2 76.37 ± 1.73 1.8096 0.06653 0.524 
CFF3 59.55 ± 1.29 1.9639 0.05855 0.979 
CFF4 58.54 ± 1.31 2.1406 0.06302 0.923 
CFF5 86.02 ± 1.54 1.8513 0.08802 0.824 
CFF6 80.52 ± 1.35 2.1094 0.08503 0.926 
CFF7 36.99 ± 1.38 0.7965 0.01992 0.964 
CFF8 46.39 ± 1.24 0.9954 0.02664 0.991 
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Formulation Zero order 
model 
First order 
model 
Higuchi model Peppas 
equation 
CFF1 0.9777 0.9370 0.9727 0.9624 
CFF2 0.9419 0.9056 0.9414 0.9407 
CFF3 0.9936 0.9901 0.9800 0.9915 
CFF4 0.9795 0.9794 0.9774 0.9652 
CFF5 0.9839 0.9837 0.9829 0.9715 
CFF6 0.9898 0.9816 0.9878 0.9875 
CFF7 0.9878 0.9875 0.9476 0.9867 
CFF8 0.9975 0.9934 0.9624 0.9953 
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Floating tablets each containing 50 mg of carbamazepine 
(CBZ) could be prepared employing starch-urea-borate as 
floating matrix former and release retardant, sodium 
bicarbonate as gas generating agent, bees wax and ethyl 
cellulose as floating enhancers by melt granulation 
technique. Hardness of the tablets was in the range of 5-6 
kg/sq.cm. Weight loss in the friability test was less than 0.18 
% in all the cases. All the matrix tablets prepared contained 
carbamazepine with in 100 ± 5 % of the labelled claim. All 
the tablets were found to be non-disintegrating in water and 
aqueous acidic (pH 1.2) and alkaline (pH 7.4) fluids. As such 
the prepared tablets were of good quality with regard to 
drug content, hardness and friability. In the in vitro buoyancy 
study variations were observed in the floating lag time as 
well as the floating time (Table 5 & Fig. 4). 
Carbamazepine release profiles of the floating tablets are 
shown Fig.5-12. Carbamazepine  release from the floating 
tablets was slow and spread over more than 24 h and 
depended on the composition of the matrix i.e., 
concentration of sodium bicarbonate, bees wax and ethyl 
cellulose. 
The dissolution data of batches CFF1 to CFF8 was fitted to 
zero-order, first order, Korsmeyer and Peppas, and Higuchi 
models. The results of Correlation coefficient (R2) were used 
to select the most appropriate model. The release profile of 
formulations CFF1-CFF8 fitted best to zero-order model 
(Table 6). Thus, it may be concluded that drug release from 
the floating carbamazepine tablets is best explained by zero 
order model.  
Percent drug released versus square root of time were found 
to be linear indicating that the drug release from the floating 
tablets prepared was diffusion controlled. The release data 
was also analyzed by the Korsmeyer and Peppas equation 
shown below in order to assess the release mechanism. 
Mt / M∞ = Ktn.                                         ---- Eq(1)      
Log (Mt / M∞) = Log K + n Log t               ---- Eq(2) 
In the above equation, Mt / M∞ is the fractional release of the 
drug, t is the release time, K is the constant for incorporating 
structural and geometric characteristics of the release device 
and n is the release exponent that could be used to 
characterize the different release mechanism as, n = 0.5 
(Fickian diffusion), 0.5 < n < 1 non-fickian (anomalous 
transport), n = 1 (case II transport; i.e., zero order release), 
and n > 1 (super case II transport). Release exponent ‘n’ was 
in the range 0.524-0.991 with all the floating tablets 
prepared indicating drug release from all these formulations 
was by non-fickian (anomalous) diffusion. 
All the release parameters (Table 7) indicated much 
variation in the drug release from the floating tablets 
formulated. To evaluate the individual and combined effects 
of the three factors involved, floating tablets were 
formulated employing selected combinations of the factors 
as per 23-factorial design. The floating times and release 
parameters (percent drug released in 24 h) of the floating 
tablets formulated were analyzed as per ANOVA of 23-
factorial design. ANOVA of floating times (Table 8) indicated 
that the individual effects of sodium bicarbonate (A), ethyl 
cellulose (B) and bees wax (C) as well as the combined 
effects of all the three (ABC) factors on the floating time of 
tablets were significant (P<0.05). The combined effects of 
any two factors (AB, AC, BC) on the floating time were not 
significant (P>0.05). 
ANOVA of release parameter (Table 9) indicated, percent 
release at the end of 24 h is significantly influenced by ethyl 
cellulose (B) and interaction between ethyl cellulose and 
bees wax (BC) (P<0.05) only. Effects of other factors were 
not significant (P>0.05). The ANOVA results, thus indicated 
that the three factors, sodium bicarbonate (A), ethyl cellulose 
(B), bees wax (C) and interaction between sodium 
bicarbonate, ethyl cellulose and bees wax (ABC) significantly 
influence the floating time of the carbamazepine floating 
tablets where as ethyl cellulose (B), and interaction between 
ethyl cellulose & bees wax (BC) significantly influence the 
drug release characteristics of the floating tablets 
formulated.
 
Table 8: ANOVA of Floating Times of Carbamazepine Floating Tablets Formulated Employing Starch-urea-borate. 
Source of Variation d.f S.S M.S.S Variance Ratio 
(F) 
Result 
Replicates 2 231.02 115.51 0.8467 P>0.05 
Treatments 7 917.46 1131.06 8.29 P< 0.05 
Sodium bicarbonate (A) 1 3082.66 3082.66 22.59 P <0.05 
Ethyl cellulose (B) 1 1568.16 1568.16 11.49 P <0.05 
Sodium bicarbonate x Ethyl cellulose (AB) 1 66.66 66.66 0.4886 P> 0.05 
Bees wax (C) 1 1734 1734 12.71 P< 0.05 
Sodium bicarbonate x Bees wax (AC) 1 9.375 9.375 0.0687 P >0.05 
Ethyl cellulose x Bees wax (BC) 1 12.04 12.04 0.0882 P> 0.05 
Sodium bicarbonate x Ethyl cellulose x Bees wax (ABC) 1 1962.04 1962.04 14.38 P <0.05 
Error 14 1909.98 136.42   
Total 23 10058.46    
P<0.05 indicate significance; P>0.05 indicate non-significance 
Where, d.f = degress of freedom, S.S = sum of squares, M.S.S = mean sum of squares 
 
 
 
 
 
 
 
 Santosh Kumar et al                                                                                            Journal of Drug Delivery & Therapeutics. 2019; 9(2):285-295 
ISSN: 2250-1177                                                                                     [295]                                                                                     CODEN (USA): JDDTAO 
Table 9: ANOVA of Release Parameter of Carbamazepine Floating Tablets Formulated Employing Starch-urea-borate. 
Source of Variation d.f S.S M.S.S Variance Ratio 
(F) 
Result 
Replicates 2 313.454 156.727 5.021 P>0.05 
Treatments 7 6322.717 903.24 28.94 P< 0.05 
Sodium bicarbonate (A) 1 7.65 7.65 0.2451 P >0.05 
Ethyl cellulose (B) 1 5033.53 5033.53 161.27 P <0.05 
Sodium bicarbonate x Ethyl cellulose (AB) 1 59.50 59.50 1.9064 P >0.05 
Bees wax (C) 1 141.08 141.08 4.520 P >0.05 
Sodium bicarbonate x Bees wax (AC) 1 2.80 208. 0.0897 P >0.05 
Ethyl cellulose x Bees wax (BC) 1 259.01 259.01 8.298 P<0.05 
Sodium bicarbonate x Ethyl cellulose x Bees wax (ABC) 1 127.19 127.19 4.075 P >0.05 
Error 14 437.05 31.21   
Total 23 7073.217    
P<0.05 indicate significance; P>0.05 indicate non-significance 
Where, d.f = degress of freedom, S.S = sum of squares, M.S.S = mean sum of squares 
 
CONCLUSION                                                          
Starch-urea-borate is an efficient matrix former for floating 
tablets based on gas generation principle. Drug release from 
the prepared tablets was slow and spread over more than 24 
h and depended on the composition of the matrix i.e., 
concentration of sodium bicarbonate, bees wax and ethyl 
cellulose. Carbamazepine release was diffusion controlled 
and followed zero order kinetics. Non-fickian diffusion was 
the drug release mechanism from the prepared floating 
tablets. Floating tablets formulated employing sodium 
bicarbonate (10%), ethyl cellulose (10%) and bees wax 
(20%) and starch-urea-borate as matrix former exhibited in 
vitro buoyancy over 43 h and good controlled release over 
more than 24 h  fulfilling USP specification and were found 
suitable for once – a-day administration. 
Optimization of carbamazepine floating tablets is a complex 
process when a new starch based polymer, starch-urea-
borate is used as a matrix former, which requires to consider 
a large number of variables and their interactions with each 
other. The present study conclusively demonstrates the use 
of 23 – factorial design in optimization of carbamazepine 
floating tablets.. The effervescent-based floating drug 
delivery is a promising approach to achieve in vitro 
buoyancy by using Starch-urea-borate, a new modified 
starch as a matrix former, sodium bicarbonate as gas-
generating agent, ethyl cellulose and bees wax as floating 
enhancers.  
The optimized formulation (CFF5) gives the best result in 
terms of the required lag time, floating duration, and drug 
release which was in accordance with the USP dissolution 
criteria for extended release tablets of carbamazepine. It is 
thus concluded that by adopting systematic approach, an 
optimum point can be reached in shortest time with 
minimum efforts when starch-urea-borate, a new modified 
starch is used as a floating matrix former for achieving 
floating formulations. 
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